Latest Breaking News On - Yissum research - Page 1 : comparemela.com

Why Clearmind Medicine Stock Is Moving Higher - Clearmind Medicine (NASDAQ:CMND)

Why Clearmind Medicine Stock Is Moving Higher - Clearmind Medicine (NASDAQ:CMND)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Ahmend masaewaAdi zullof shaniAvi prielYissum research developmentClearmind medicine incHebrew universityYissum researchClearmind medicineRami yakaHave this to say about omega

Innocan Pharma Announces Clinical Study Results: Evidence of Reduced Osteoarthritis Pain in Dogs After Liposomal CBD Injection

/PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce the results of a clinical.

Israel generalHebrew universityChezy barenholzInnocan pharmaIris bincovichHebrew university of jerusalemInnocan pharma corporationInnocan pharma ltdYissum researchLiposome research departmentDevelopment company yissumTel aviv universityVeterinary sciencePharma ltdDevelopment companyProfessor chezy barenholz

Innocan Pharma Corporation: Innocan Pharma Announces Clinical Study Results: Evidence of Reduced Osteoarthritis Pain in Dogs After Liposomal CBD Injection

Innocan Pharma Corporation: Innocan Pharma Announces Clinical Study Results: Evidence of Reduced Osteoarthritis Pain in Dogs After Liposomal CBD Injection
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Hebrew universityIsrael generalTel avivInnocan pharmaIris bincovichChezy barenholzPrnewswire innocan pharma corporationLiposome research departmentInnocan pharma corporationHebrew university of jerusalemInnocan pharma ltdYissum researchCompany or innocanTel aviv universityDevelopment company yissumPharma corporation

Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suffering from Refractory (Drug-Resistant) Epilepsy Following LPT Treatment

Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suffering from Refractory (Drug-Resistant) Epilepsy Following LPT Treatment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel generalTel avivHebrew universityIris bincovichChezy barenholzInnocan pharmaDevelopment company yissumCompany or innocanInnocan pharma corporationLiposome research departmentMarket researchInnocan pharma ltdHebrew university of jerusalemAlberta newsfile corpTel aviv universityYissum research

Innocan Pharma Corporation: Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suffering from Refractory (Drug-Resistant) Epilepsy Following LPT Treatment

A 4-year-old intact male border collie dog with a body weight of 22 kg was suffering from refractory idiopathic (drug-resistant) epilepsyThe dog was frequently hospitalized to stop seizure clusters Following

Israel generalTel avivHebrew universityIris bincovichChezy barenholzInnocan pharmaDevelopment company yissumCompany or innocanInnocan pharma corporationLiposome research departmentMarket researchInnocan pharma ltdHebrew university of jerusalemAlberta newsfile corpTel aviv universityYissum research